Lan, Tingzhu
Vitamin E succinate inhibits the growth of human gastric cancer cells - Vol.83(2), March-April - Mumbai Indian Journal of Pharmaceutical Science 2021 - 346-353p.
Gastric cancer is the most common malignant tumor disease in the human digestive system. It ranks first
in the incidence of cancer-related diseases in China. It is a serious threat to the health of Chinese people.
Vitamin E Succinate is a natural Vitamin E derivative and has been confirmed to have an inhibitory effect
on tumor cell growth. Based on this, the article explores the e ffect of Vitamin E Succinate on inhibiting
the growth of human gastric cancer cells and aims to provide a reference for the clinical diagnosis and
treatment of gastric cancer. This articlefirst systematically introduces Vitamin E Succinate and the related
theoretical knowledge of gastric cancer and lays a su fficient theoretical foundation for the following
research on Vitamin E Succinate inhibiting the growth of human gastric cancer cells and inducing apoptosis
of gastric cancer cells. The human gastric cancer cell specimens and Vitamin E Succinate solution were
formulated and the effect of Vitamin E Succinate on the growth of human gastric cancer cells was tested.
According to the concentration of Vitamin E Succinate, the gastric cancer cells in the experiment were
divided into Vitamin E Succinate 10 mg/ml dose group, Vitamin E Succinate 10 mg/ml dose group, Vitamin
E Succinate 15 mg/ml dose group and the blank control group, the growth curve of gastric cancer cells, cell
colony determination, cell division index determination and cell 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide detection and analysis were used to compare the changes in cell growth between
different dose groups; the final result is that Vitamin E Succinate has a signi ficant inhibitory effect on the
growth of gastric cancer cells (p<0.05) and as the dose concentration increases and the treatment time
increases, its inhibitory effect on the cells is more significant
PHARMACEUTICS
Vitamin E succinate inhibits the growth of human gastric cancer cells - Vol.83(2), March-April - Mumbai Indian Journal of Pharmaceutical Science 2021 - 346-353p.
Gastric cancer is the most common malignant tumor disease in the human digestive system. It ranks first
in the incidence of cancer-related diseases in China. It is a serious threat to the health of Chinese people.
Vitamin E Succinate is a natural Vitamin E derivative and has been confirmed to have an inhibitory effect
on tumor cell growth. Based on this, the article explores the e ffect of Vitamin E Succinate on inhibiting
the growth of human gastric cancer cells and aims to provide a reference for the clinical diagnosis and
treatment of gastric cancer. This articlefirst systematically introduces Vitamin E Succinate and the related
theoretical knowledge of gastric cancer and lays a su fficient theoretical foundation for the following
research on Vitamin E Succinate inhibiting the growth of human gastric cancer cells and inducing apoptosis
of gastric cancer cells. The human gastric cancer cell specimens and Vitamin E Succinate solution were
formulated and the effect of Vitamin E Succinate on the growth of human gastric cancer cells was tested.
According to the concentration of Vitamin E Succinate, the gastric cancer cells in the experiment were
divided into Vitamin E Succinate 10 mg/ml dose group, Vitamin E Succinate 10 mg/ml dose group, Vitamin
E Succinate 15 mg/ml dose group and the blank control group, the growth curve of gastric cancer cells, cell
colony determination, cell division index determination and cell 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide detection and analysis were used to compare the changes in cell growth between
different dose groups; the final result is that Vitamin E Succinate has a signi ficant inhibitory effect on the
growth of gastric cancer cells (p<0.05) and as the dose concentration increases and the treatment time
increases, its inhibitory effect on the cells is more significant
PHARMACEUTICS